AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9758574 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary angioplasty
Number of subjects: 409
Study 9758574 — intervention group
Group type: COMPARATOR
Intervention: Coronary bypass surgery
Number of subjects: 409
Study 7818585 — intervention group
Group type: EXPERIMENTAL
Intervention: roxatidine (150 mg daily) with diclofenac (100 mg daily)
Number of subjects: 44
Study 7818585 — intervention group
Group type: COMPARATOR
Intervention: diclofenac (100 mg daily) with placebo
Number of subjects: 44
Study 7818585 — intervention group
Group type: EXPERIMENTAL
Intervention: misoprostol (200 micrograms bid) with diclofenac (100 mg daily)
Number of subjects: 44
Study 7818585 — intervention group
Group type: EXPERIMENTAL
Intervention: diclofenac (100 mg daily) with roxatidine (150 mg daily)
Number of subjects: 44
Study 3276865 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma infusion (P+ group)
Number of subjects: 32
Study 3276865 — intervention group
Group type: COMPARATOR
Intervention: Symptomatic therapy (P- group)
Number of subjects: 32
Study 31055011 — intervention group
Group type: EXPERIMENTAL
Intervention: Ads featuring Black actors
Number of subjects: 0
Study 31055011 — intervention group
Group type: COMPARATOR
Intervention: Ads featuring White actors
Number of subjects: 0
Study 31055011 — intervention group
Group type: EXPERIMENTAL
Intervention: Ads featuring Blacks
Number of subjects: 0
Study 28064525 — intervention group
Group type: EXPERIMENTAL
Intervention: Wellness Journey (healthy lifestyle intervention)
Number of subjects: 450
Study 28064525 — intervention group
Group type: COMPARATOR
Intervention: Safety Journey (child safety control group)
Number of subjects: 450
Study 26047957 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training program (12 weeks, 8 exercises, 2 sets, 10-15 repetitions, 3 days/week)
Number of subjects: 28
Study 26047957 — intervention group
Group type: COMPARATOR
Intervention: Stretching exercises (12 weeks, 2 sets, 20 s each, 2 days/week)
Number of subjects: 28
Study 26047957 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training program (after intervention)
Number of subjects: 28
Study 26047957 — intervention group
Group type: COMPARATOR
Intervention: Stretching exercises (after intervention)
Number of subjects: 28
Study 24018103 — intervention group
Group type: EXPERIMENTAL
Intervention: SLC18A2 gene SNPs (specifically rs2015586 and rs363224)
Number of subjects: 217
Study 24018103 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction of rs363224 with D2 receptor rs6277 (C957T) polymorphism
Number of subjects: 217
Study 21262997 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise
Number of subjects: 119
Study 21262997 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise
Number of subjects: 119
Study 21262997 — intervention group
Group type: COMPARATOR
Intervention: Usual-care control
Number of subjects: 119
Study 18006647 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg of [(14)C]dabigatran etexilate (oral prodrug)
Number of subjects: 10
Study 18006647 — intervention group
Group type: COMPARATOR
Intervention: 5 mg of [(14)C]dabigatran (i.v. infusion)
Number of subjects: 10
Study 16448817 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI with a novel splint that stresses the knee
Number of subjects: 14
Study 16448817 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal subjects)
Number of subjects: 14
Study 15043790 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 19287
Study 15043790 — intervention group
Group type: COMPARATOR
Intervention: Oxytocin
Number of subjects: 19287
Study 11118564 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertaconazole 300 mg suppository
Number of subjects: 369
Study 11118564 — intervention group
Group type: COMPARATOR
Intervention: Econazole 150 mg suppository
Number of subjects: 369
Study 9345696 — intervention group
Group type: EXPERIMENTAL
Intervention: Alzheimer's disease (AD) participants
Number of subjects: 0
Study 9345696 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcortical ischemic vascular dementia (IVD) participants
Number of subjects: 0
Study 9345696 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 8475322 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam (0.25 mg)
Number of subjects: 0
Study 8475322 — intervention group
Group type: EXPERIMENTAL
Intervention: Other hypnotics
Number of subjects: 0
Study 8475322 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8475322 — intervention group
Group type: EXPERIMENTAL
Intervention: Residual effects of hypnotics
Number of subjects: 0
Study 2417648 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound therapy (US) at 1.5 W.cm-2
Number of subjects: 150
Study 2417648 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound therapy (US) at 0.1 W.cm-2
Number of subjects: 150
Study 2417648 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound therapy (US) at 0.5 W.cm-2
Number of subjects: 150
Study 2417648 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo group ('mock' US)
Number of subjects: 150
Study 2417648 — intervention group
Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 150
Study 29788802 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled menthol (0.0%, 0.5%, and 3.2%)
Number of subjects: 57
Study 29788802 — intervention group
Group type: COMPARATOR
Intervention: Saline and nicotine infusions (0.25 mg and 0.5 mg/70 kg)
Number of subjects: 57
Study 26858092 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced-air convective warming at 46°C for one hour
Number of subjects: 32
Study 26858092 — intervention group
Group type: COMPARATOR
Intervention: Routine care (full body blanket with convective warmer attached but not turned on)
Number of subjects: 32
Study 25185255 — intervention group
Group type: EXPERIMENTAL
Intervention: INTRACOR procedure with six concentric intrastromal ring cuts
Number of subjects: 20
Study 22954721 — intervention group
Group type: COMPARATOR
Intervention: Rotigotine transdermal system
Number of subjects: 0
Study 20684440 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride releasing materials (glass ionomers, resin modified glass ionomers, compomers)
Number of subjects: 1341
Study 20684440 — intervention group
Group type: COMPARATOR
Intervention: Amalgam
Number of subjects: 1341
Study 18208463 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% methylprednisolone aceponate cream + emollients (Group B)
Number of subjects: 52
Study 18208463 — intervention group
Group type: COMPARATOR
Intervention: 0.1% methylprednisolone aceponate cream (Group A)
Number of subjects: 52
Study 17010794 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombus aspiration before PCI
Number of subjects: 50
Study 17010794 — intervention group
Group type: COMPARATOR
Intervention: Standard PCI (Control)
Number of subjects: 50
Study 14582594 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect resin composite inlays/onlays (Tetric, Z100, Maxxim)
Number of subjects: 25
Study 10753981 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional-intensity warfarin therapy (INR 2.2 to 3.5)
Number of subjects: 115
Study 10753981 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity warfarin therapy (INR 1.5 to 2.1)
Number of subjects: 115
Study 9279294 — intervention group
Group type: EXPERIMENTAL
Intervention: Bambuterol 20 mg
Number of subjects: 31
Study 9279294 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 7512462 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrendipine
Number of subjects: 0
Study 7512462 — intervention group
Group type: COMPARATOR
Intervention: Verapamil
Number of subjects: 0
Study 7512462 — intervention group
Group type: COMPARATOR
Intervention: Diltiazem
Number of subjects: 0
Study 7512462 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3555359 — intervention group
Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate 50 mg intramuscularly every third week for two years
Number of subjects: 47
Study 3555359 — intervention group
Group type: COMPARATOR
Intervention: No anabolic steroids (Control)
Number of subjects: 47
Study 29922752 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual‐cure self‐adhesive composite cement (Multilink Speed, Ivoclar Vivadent) light-cured for 20 s
Number of subjects: 40
Study 29922752 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual‐cure self‐adhesive composite cement (Multilink Speed, Ivoclar Vivadent) light-cured for 40 s
Number of subjects: 40
Study 29922752 — intervention group
Group type: COMPARATOR
Intervention: Control group (20-degree and 30-degree zirconia surfaces)
Number of subjects: 40
Study 28511500 — intervention group
Group type: EXPERIMENTAL
Intervention: HiOra mouthwash
Number of subjects: 45
Study 28511500 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic mouthwash
Number of subjects: 45
Study 28511500 — intervention group
Group type: COMPARATOR
Intervention: CHX mouthwash
Number of subjects: 45
Study 25677642 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 90
Study 25677642 — intervention group
Group type: COMPARATOR
Intervention: Insulin detemir plus sitagliptin
Number of subjects: 90
Study 23545909 — intervention group
Group type: EXPERIMENTAL
Intervention: Tretinoin 0.025%/clindamycin phosphate 1.2% gel in combination with benzoyl peroxide 6% foaming cloth
Number of subjects: 0
Study 23545909 — intervention group
Group type: COMPARATOR
Intervention: Tretinoin 0.025%/clindamycin phosphate 1.2% gel alone
Number of subjects: 0
Study 20042524 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-sodium diet
Number of subjects: 210
Study 20042524 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 210
Study 18405146 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 66
Study 18405146 — intervention group
Group type: COMPARATOR
Intervention: nCPAP
Number of subjects: 66
Study 16870083 — intervention group
Group type: EXPERIMENTAL
Intervention: Goshuyuto
Number of subjects: 53
Study 16870083 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 12823170 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-factor and two psychopathology factors as mediators of self-rated quality of life
Number of subjects: 117
Study 12823170 — intervention group
Group type: EXPERIMENTAL
Intervention: Trait-like properties such as the self-factor and personality
Number of subjects: 117
Study 10629624 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamidronate 60 mg i.v. q 4 weeks
Number of subjects: 404
Study 10629624 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 404
Study 7560474 — intervention group
Group type: EXPERIMENTAL
Intervention: Noradrenaline (0.14 microgram/kg min)
Number of subjects: 9
Study 7560474 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenaline (0.08 microgram/kg min)
Number of subjects: 9
Study 7560474 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine (7 micrograms/kg min)
Number of subjects: 9
Study 7560474 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 9
Study 1933707 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 gel (0.5 mg in 2.5 mL)
Number of subjects: 397
Study 1933707 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel (2.5 mL)
Number of subjects: 397
Study 7141686 — intervention group
Group type: EXPERIMENTAL
Intervention: Live influenza A/Victoria/75 (H3N2) recombinant virus vaccine with ts‐1[E] (38 degrees C shut‐off temperature)
Number of subjects: 50
Study 7141686 — intervention group
Group type: EXPERIMENTAL
Intervention: Live influenza A/Victoria/75 (H3N2) recombinant virus vaccine with ts‐1A2 (37 degrees C shut‐off temperature)
Number of subjects: 50
Study 7141686 — intervention group
Group type: EXPERIMENTAL
Intervention: Live influenza A/Victoria/75 (H3N2) recombinant virus vaccines with cold‐adapted A/Ann Arbor/6/60
Number of subjects: 50
Study 7141686 — intervention group
Group type: EXPERIMENTAL
Intervention: Live influenza A/Victoria/75 (H3N2) recombinant virus vaccines
Number of subjects: 50
Study 7141686 — intervention group
Group type: EXPERIMENTAL
Intervention: Wild-type A/Victoria/75 virus challenge in vaccinated volunteers
Number of subjects: 50
Study 7141686 — intervention group
Group type: COMPARATOR
Intervention: Unvaccinated volunteers with little or no serum antibody
Number of subjects: 50
Study 4056259 — intervention group
Group type: EXPERIMENTAL
Intervention: Dp standardized extract
Number of subjects: 30
Study 4056259 — intervention group
Group type: COMPARATOR
Intervention: Placebo extract
Number of subjects: 30
Study 4056259 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study 31125720 — intervention group
Group type: EXPERIMENTAL
Intervention: Valveless insufflation system at IAP 10 mm Hg
Number of subjects: 132
Study 31125720 — intervention group
Group type: EXPERIMENTAL
Intervention: Valveless insufflation system at IAP 15 mm Hg
Number of subjects: 132
Study 31125720 — intervention group
Group type: COMPARATOR
Intervention: Standard insufflation at IAP 10 mm Hg
Number of subjects: 132
Study 31125720 — intervention group
Group type: COMPARATOR
Intervention: Standard insufflation at IAP 15 mm Hg
Number of subjects: 132
Study 31125720 — intervention group
Group type: EXPERIMENTAL
Intervention: Valveless insufflation (both pressures)
Number of subjects: 132
Study 31125720 — intervention group
Group type: COMPARATOR
Intervention: Standard insufflation (both pressures)
Number of subjects: 132
Study 31125720 — intervention group
Group type: EXPERIMENTAL
Intervention: Both systems
Number of subjects: 132
Study 29461654 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured aerobic and resistance exercise program performed twice per week, including 20 minutes of aerobic exercise, 20-25 minutes of resistance exercise, and 10 minutes of cool down.
Number of subjects: 18
Study 28178072 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg diclofenac + 1.2 mg atropine
Number of subjects: 100
Study 28178072 — intervention group
Group type: COMPARATOR
Intervention: Placebo + 1.2 mg atropine
Number of subjects: 100
Study 28178072 — intervention group
Group type: COMPARATOR
Intervention: 100 mg diclofenac + placebo
Number of subjects: 100
Study 28178072 — intervention group
Group type: COMPARATOR
Intervention: Placebo + placebo
Number of subjects: 100
Study 25793927 — intervention group
Group type: EXPERIMENTAL
Intervention: Magazine article endorsing non-medicalized birth (celebrity or non-celebrity endorsement)
Number of subjects: 180
Study 25793927 — intervention group
Group type: COMPARATOR
Intervention: Organic eating (control)
Number of subjects: 180
Study 24392486 — intervention group
Group type: EXPERIMENTAL
Intervention: FRC+PFC (photopolymerized in one step)
Number of subjects: 144
Study 24392486 — intervention group
Group type: EXPERIMENTAL
Intervention: FRC+FR (photopolymerized in one step)
Number of subjects: 144
Study 24392486 — intervention group
Group type: EXPERIMENTAL
Intervention: FRC+PFC (photopolymerized individually)
Number of subjects: 144
Study 24392486 — intervention group
Group type: EXPERIMENTAL
Intervention: FRC+FR (photopolymerized individually)
Number of subjects: 144
Study 24392486 — intervention group
Group type: EXPERIMENTAL
Intervention: FRC (photopolymerized)+intermediate adhesive resin and PFC (photopolymerized in one step)
Number of subjects: 144
Study 24392486 — intervention group
Group type: EXPERIMENTAL
Intervention: FRC (photopolymerized)+intermediate adhesive resin and FR (photopolymerized in one step)
Number of subjects: 144
Study 24392486 — intervention group
Group type: COMPARATOR
Intervention: Multidirectional FRC groups (g to l)
Number of subjects: 144
Study 24392486 — intervention group
Group type: COMPARATOR
Intervention: Unidirectional FRC groups (a to f)
Number of subjects: 144
Study 24392486 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermogravimetric analysis (TGA)
Number of subjects: 144
Study 21180658 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucocorticoid administration
Number of subjects: 0
Study 21180658 — intervention group
Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 0
Study 19026301 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote Ischemic Preconditioning (RIPC)
Number of subjects: 184
Study 19026301 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 184
Study 16791287 — intervention group
Group type: EXPERIMENTAL
Intervention: AdVEGF121 gene transfer via mini-thoracotomy
Number of subjects: 67
Study 16791287 — intervention group
Group type: COMPARATOR
Intervention: Control group (maximum medical treatment)
Number of subjects: 67
Study 12589536 — intervention group
Group type: EXPERIMENTAL
Intervention: NIV with helmet (group H) for 1 hour, flow-triggered pressure support 10 cmH(2)O, PEEP 5 cmH(2)O, FiO(2) 0.21
Number of subjects: 10
Study 12589536 — intervention group
Group type: COMPARATOR
Intervention: NIV with facial mask (group M) for 1 hour, flow-triggered pressure support 10 cmH(2)O, PEEP 5 cmH(2)O, FiO(2) 0.21
Number of subjects: 10
Study 12589536 — intervention group
Group type: EXPERIMENTAL
Intervention: NIV with helmet (group H)
Number of subjects: 10
Study 12589536 — intervention group
Group type: COMPARATOR
Intervention: NIV with facial mask (group M)
Number of subjects: 10
Study 11053711 — intervention group
Group type: EXPERIMENTAL
Intervention: Ross operation (pulmonary autograft in aortic position)
Number of subjects: 32
Study 11053711 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 32
Study 9113547 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed suction drains after total knee arthroplasty
Number of subjects: 88
Study 9113547 — intervention group
Group type: COMPARATOR
Intervention: No closed suction drains after total knee arthroplasty
Number of subjects: 88
Study 9113547 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed suction drains after total hip arthroplasty
Number of subjects: 88
Study 9113547 — intervention group
Group type: COMPARATOR
Intervention: No closed suction drains after total hip arthroplasty
Number of subjects: 88
Study 9113547 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed suction drains
Number of subjects: 88
Study 9113547 — intervention group
Group type: COMPARATOR
Intervention: No closed suction drains
Number of subjects: 88
Study 8211453 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulphur dioxide (SO2) challenge in apple juice
Number of subjects: 37
Study 8211453 — intervention group
Group type: COMPARATOR
Intervention: Apple juice alone (control)
Number of subjects: 37
Study 3542942 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (100 mg bd for five days)
Number of subjects: 40
Study 3542942 — intervention group
Group type: COMPARATOR
Intervention: Trimethoprim (200 mg bd for five days)
Number of subjects: 40
Study 30445718 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein (HP) dietary guidelines
Number of subjects: 27
Study 30445718 — intervention group
Group type: COMPARATOR
Intervention: Medium protein (MP) dietary guidelines
Number of subjects: 27
Study 30445718 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole group (both HP and MP)
Number of subjects: 27
Study 27473760 — intervention group
Group type: EXPERIMENTAL
Intervention: Responsiveness Index (RI) monitoring
Number of subjects: 881
Study 27473760 — intervention group
Group type: EXPERIMENTAL
Intervention: Online education programme
Number of subjects: 881
Study 27473760 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedation-analgesia quality feedback
Number of subjects: 881
Study 24826474 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior transpedicular screw-plate system (Group A)
Number of subjects: 16
Study 24826474 — intervention group
Group type: COMPARATOR
Intervention: Vertebral body screw-plate system (Group B)
Number of subjects: 16
Study 22697452 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent‐Child Interaction Therapy (PCIT)
Number of subjects: 28
Study 22697452 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 28
Study 21036569 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained tutors
Number of subjects: 20
Study 21036569 — intervention group
Group type: COMPARATOR
Intervention: Untrained tutors (control group)
Number of subjects: 20
Study 17889864 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-assisted hatching (opening zona pellucida using an infrared optical laser system on the day of embryo transfer)
Number of subjects: 1386
Study 17889864 — intervention group
Group type: COMPARATOR
Intervention: Control (intact zona pellucida)
Number of subjects: 1386
Study 17889864 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-assisted hatching
Number of subjects: 1386
Study 16735966 — intervention group
Group type: EXPERIMENTAL
Intervention: gliclazide
Number of subjects: 30
Study 16735966 — intervention group
Group type: COMPARATOR
Intervention: glibenclamide
Number of subjects: 30
Study 12823643 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (81 mg)
Number of subjects: 149
Study 12823643 — intervention group
Group type: EXPERIMENTAL
Intervention: B-vitamins (folic acid 2 mg and vitamin B12 1 mg)
Number of subjects: 149
Study 12823643 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant vitamins (vitamin E 500 mg and vitamin C 200 mg)
Number of subjects: 149
Study 12823643 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study 10910802 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg of hydrocortisone
Number of subjects: 22
Study 10910802 — intervention group
Group type: COMPARATOR
Intervention: 1 mg/kg of ovine CRH
Number of subjects: 22
Study 10910802 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 22
Study 8955969 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline (5 mg in 2 ml normal saline)
Number of subjects: 131
Study 8955969 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (4 ml)
Number of subjects: 131
Study 8955969 — intervention group
Group type: COMPARATOR
Intervention: Sterile water iv instead of fentanyl
Number of subjects: 131
Study 8955969 — intervention group
Group type: COMPARATOR
Intervention: Atropine (0.01 mg.kg-1, iv)
Number of subjects: 131
Study 1287983 — intervention group
Group type: EXPERIMENTAL
Intervention: Judgement of squareness
Number of subjects: 0
Study 1287983 — intervention group
Group type: EXPERIMENTAL
Intervention: Judgement of circularity
Number of subjects: 0
Study 1287983 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspect ratio discrimination threshold
Number of subjects: 0
Study 1287983 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspect ratio discrimination threshold for rectangles and ellipses
Number of subjects: 0